Webinar Wednesday: Mariano Severgnini from Dana-Farber Cancer Institute
Soluble Biomarker Detection in Cancer Patients Treated with Immunotherapies using xMAP® Technology
For our fourth Webinar Wednesday blog, we’re featuring a talk from Mariano Severgnini, who is the lead scientist at the Immune Assessment Lab (IAL) in the Center for Immuno-Oncology (CIO) at Dana-Farber Cancer Institute. The IAL serves as the focal point for immunotherapy clinical trials by providing expertise in sample banking and processing as well as assay development and execution for immune monitoring.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
AACR Annual Meeting
Clinical Virology Symposium (CVS)
West Palm Beach, FL
PSI Annual Meeting
Beurs Van Berlage, Amsterdam
International Precision Vaccines Conference